Walleye Capital LLC Liquidia Corp Put Options Transaction History

Walleye Capital LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2024 Aug 14, 2024	SELL	$11.96 - $15.71 $770,224 - $1.01 Million	-64,400 Reduced 72.6%	24,300 $291,000
Q1 2024 May 15, 2024	BUY	$11.35 - $16.73 $926,160 - $1.37 Million	81,600 Added 1149.3%	88,700 $1.31 Million
Q4 2023 Feb 14, 2024	SELL	$5.77 - $12.19 $43,852 - $92,644	-7,600 Reduced 51.7%	7,100 $85,000
Q3 2023 Nov 14, 2023	BUY	$6.27 - $8.15 $92,169 - $119,805	14,700 New	14,700 $93,000

163

36M

1.79M

380K

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $709M
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.